Sign inJoin waitlistJoin the waitlist

Natalie Byrne

Neurology Residency · University of Kansas School of Medicine

Credentials: · · ·

History

Neurology
University of Kansas School of Medicine
2023–Present
The St. Louis College of Pharmacy
Univ of Kansas Sch of Med
2019–2023
The St
2015–2019

Research

Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label,…
The Lancet · 2019 · 1,945 citations
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN):…
The Lancet Oncology · 2021 · 600 citations
Circulating Tumor DNA Reflects Uveal Melanoma Responses to Protein Kinase C Inhibition
Cancers · 2021 · 30 citations